Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
about
Glial Modulation by N-acylethanolamides in Brain Injury and NeurodegenerationPalmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic RetinopathyAntineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityLuteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.Hydrogen Sulfide Ameliorates Homocysteine-Induced Cognitive Dysfunction by Inhibition of Reactive Aldehydes Involving Upregulation of ALDH2Interaction of Aβ(25-35) fibrillation products with mitochondria: Effect of small-molecule natural products.Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminalsOxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheresOral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.The dynamics of monocytes and microglia in Alzheimer's disease.N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.An update on PPAR activation by cannabinoids.PPARα activation attenuates amyloid-β-dependent neurodegeneration by modulating Endo G and AIF translocation.Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.Delay of morphine tolerance by palmitoylethanolamide.Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.Behavioral Phenotyping for Autism Spectrum Disorders in Mice.Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain.Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence.N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review.
P2860
Q26747533-36C15C57-9D0D-4A2A-BD48-AE90EDED21B6Q26776171-9E7EC674-7CF3-4D4A-B448-681407173565Q27305830-11E978A6-8BA4-4A95-9AD0-68568A89CFCEQ30354338-A7472E5C-2AEE-4C9C-8540-25EFB8461561Q31122398-DADD9BF1-85A1-4C9C-94FD-D31415DC2D7DQ33614493-F6F76AA8-AC27-4222-8D1D-C74C3553ED68Q35314500-336013F5-23B8-44F1-95BF-7961F36BAC45Q35381177-F7D5D398-D5E4-494C-989D-72FFBD488F94Q35564173-7F7ADB4D-8511-4752-9C1F-5E803344ACFDQ36348374-1BC15115-1C3A-4727-B727-6DE7029FA48CQ36525591-F986992D-3055-4DD2-9A17-57C20EEDF185Q36775237-D42715A5-9863-4DBF-B396-EED110029D75Q37097418-C3C1437A-A809-44E2-BB32-341690BC7EEEQ38118187-9C118801-A9E1-4CFC-B0D9-E86A8E22A52CQ38423147-8AF68ACF-451A-44AC-84BA-A7D48D6EA7E3Q38599291-82ECBFDD-F459-4B07-8AA9-1EE47C6B3B42Q38808034-3A6917EE-9289-48F9-928E-B23C7F5B8512Q38973115-E75A6195-4F0F-4FDF-ADF4-9773D281945FQ39230043-384D443E-0EAE-48A0-9EE8-7EA9DF7980B6Q39759653-99E8B057-0EF5-4840-A80E-C3F74772D9BBQ41908176-03ADC022-4B44-4C5E-91C6-C764945E2F33Q41912809-9A26E733-51B4-4D7A-9635-EDF8852E7A05Q42474130-F526ECC6-64E9-4E00-A50D-AD3B0B0CB42DQ47888666-B9E6282E-1A90-4FC5-9698-791A31485DB9Q47962439-66AB7CFF-CBD2-4CB8-8670-1C534AFCB06FQ48139053-4CC45D50-33BA-47C8-ADF9-659BD2C7D514Q52584461-0F1F096A-101E-4CF8-A05A-692F4AD9801FQ52608759-DC73A8FC-87BC-41BD-A3F2-E699E786D610Q52632555-192A349D-3957-4063-B575-0236407CFC91Q55094909-DFD51FBB-A87C-4DC7-A2E6-54BC254A7BD9Q55236616-AD045CE4-D9BF-40E8-B2C8-71003824FCC0
P2860
Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@ast
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@en
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@nl
type
label
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@ast
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@en
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@nl
prefLabel
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@ast
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@en
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@nl
P2860
P50
P356
P1476
Palmitoylethanolamide protects ...... al model of Alzheimer disease.
@en
P2093
Carmen Avagliano
Roberto Russo
P2860
P2888
P304
P356
10.1038/NPP.2012.25
P407
P577
2012-03-14T00:00:00Z
P5875
P6179
1023208366